Clinical Trial Update: Duloxetine for the Treatment of Dysthymia [NA]

View source ↗

Summary

A completed clinical trial evaluating duloxetine for persistent depressive disorder (dysthymia) sponsored by Stanford University.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Persistent Depressive Disorder

Drugs mentioned

• Duloxetine (DULOXETINE)

Snippet

Sponsor: Stanford University | Conditions: Depressive Disorder | NA | Status: COMPLETED